INTUITIVE SURGICAL INC·4

Feb 11, 5:37 PM ET

Curet Myriam 4

4 · INTUITIVE SURGICAL INC · Filed Feb 11, 2026

Research Summary

AI-generated summary of this filing

Updated

Intuitive Surgical (ISRG) EVP Myriam Curet Exercises RSUs and Sells Shares

What Happened
Myriam Curet, EVP & Chief Medical Officer of Intuitive Surgical (ISRG), had equity vest and exercised options on Feb 10, 2026, and sold shares in open-market transactions on Feb 10–11, 2026. Specifically, 943 derivative units converted into common stock (838 RSUs + 105 option shares). Of those, 417 shares were surrendered to cover tax withholding (valued at about $205,514). She also exercised 105 option shares at $229.39 per share (cost ~$24,086) and sold those 105 shares the same day at $494.65 (proceeds ~$51,938). Additional open-market sales of 421 shares occurred on Feb 11 at $494.96 (proceeds ~$208,378). Total reported open-market sale proceeds were about $260,316.

Key Details

  • Transaction dates: conversions/exercise on 2026-02-10; open-market sales on 2026-02-10 and 2026-02-11.
  • Prices & amounts: 838 RSUs converted @ $0 (vesting); 105 option shares exercised @ $229.39 (cost ~$24,086) then sold @ $494.65 (proceeds ~$51,938); 421 shares sold @ $494.96 (proceeds ~$208,378); 417 shares withheld for taxes valued @ $492.84 ( ~$205,514).
  • Proceeds: open-market sales total ≈ $260,316; tax-withheld shares ≈ $205,514.
  • Shares owned after transaction: not specified in the provided filing details.
  • Footnotes: RSUs vest 25% per year starting Feb 10, 2023 (a portion was withheld for taxes); option and RSU vesting schedules described (F1–F4). The open-market sale was executed under a 10b5-1 trading plan that expires July 29, 2026 (F2).
  • Filing timeliness: Reported on 2026-02-11 for transactions on 2026-02-10–11 (filed promptly).

Context
This filing shows routine vesting of RSUs and an option exercise followed by same-day sales (a cashless exercise/settlement pattern). The 417-share disposition was a withholding to cover tax liabilities rather than an open-market sale. The presence of a 10b5-1 plan indicates some sales were pre-arranged, which is common for executives and reduces the implication that the trades reflect short-term trading on inside information.

Insider Transaction Report

Form 4
Period: 2026-02-10
Curet Myriam
EVP & Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-02-10+8381,247 total(indirect: By Trust)
  • Tax Payment

    Common Stock

    [F1]
    2026-02-10$492.84/sh417$205,514830 total(indirect: By Trust)
  • Exercise/Conversion

    Common Stock

    [F2]
    2026-02-10$229.39/sh+105$24,086935 total(indirect: By Trust)
  • Sale

    Common Stock

    [F2]
    2026-02-10$494.65/sh105$51,938830 total(indirect: By Trust)
  • Sale

    Common Stock

    [F2]
    2026-02-11$494.96/sh421$208,378409 total(indirect: By Trust)
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    [F2][F3]
    2026-02-101051,257 total
    Exercise: $229.39Exp: 2030-02-27Common Stock (105 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    [F4]
    2026-02-10838838 total
    Exercise: $0.00Common Stock (838 underlying)
Footnotes (4)
  • [F1]RSUs vest 25% per year over a four year period, commencing on each anniversary of February 10, 2023. RSUs convert into common stock on the vest date on a one-for-one basis. 25% of the shares have been released and a portion of the shares were held back to cover the statutory tax withholding requirements. The net shares were deposited into the holders account.
  • [F2]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
  • [F3]12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
  • [F4]Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock upon vesting. 25% of the RSUs shall vest on each anniversary of February 10, 2023, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Signature
By: Stephanie Lim-Ignacio For: McAdams, Myriam Curet|2026-02-11

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT